Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Postoperative Quality of Life after Total Gastrectomy Compared with Partial Gastrectomy: Longitudinal Evaluation by European Organization for Research and Treatment of Cancer-OG25 and STO22

  • Lee, Jeong-Hwan (Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Lee, Hyuk-Joon (Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Choi, Yun Suk (Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kim, Tae Han (Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Huh, Yeon-Ju (Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Suh, Yun-Suhk (Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Kong, Seong-Ho (Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Yang, Han-Kwang (Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine)
  • Received : 2016.10.05
  • Accepted : 2016.10.17
  • Published : 2016.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The European Organization for Research and Treatment of Cancer quality-of-life questionnaire-OG25 was developed to evaluate the quality of life in patients with stomach and esophageal cancer. The following are included in the OG25 but not in the STO22: odynophagia, choked when swallowing, weight loss, trouble eating with others, trouble swallowing saliva, trouble talking, and trouble with coughing. In this study, we evaluated the quality of life of gastrectomized patients using both, the OG25 and the STO22. Materials and Methods: A total of 138 patients with partial gastrectomy (PG) (distal gastrectomy=91; pylorus-preserving gastrectomy=47) and 44 patients with total gastrectomy (TG) were prospectively evaluated. Body weight and scores from the OG25 and STO22 were evaluated preoperatively and at 3 weeks, 3 months, and 6 months after surgery. Results: Patients with TG had significant weight loss compared to patients with PG. At 3 months, TG was associated with worse scores for dysphagia, eating, odynophagia, trouble eating with others, trouble with taste, and weight loss on the OG25. TG was also associated with dysphagia, eating restrictions, and anxiety on the STO22. The OG25 helped differentiate between the groups with respect to weight loss, odynophagia, choked when swallowing, and trouble eating with others. The OG25 scores changed over time and were significantly different. Conclusions: The OG25 is a more sensitive and useful scale than the STO22 for evaluating the quality of life of gastrectomized patients, especially those with total gastrectomy.

Keywords

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90. https://doi.org/10.3322/caac.20107
  2. Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet 2016. doi: 10.1016/S0140-6736(16)30354-3 [In print].
  3. Jeong O, Park YK. Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. J Gastric Cancer 2011;11:69-77. https://doi.org/10.5230/jgc.2011.11.2.69
  4. Jung KW, Won YJ, Oh CM, Kong HJ, Cho H, Lee DH, et al. Prediction of cancer incidence and mortality in Korea, 2015. Cancer Res Treat 2015;47:142-148. https://doi.org/10.4143/crt.2015.066
  5. Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G, Nakao A. Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg 2011;35:357-364. https://doi.org/10.1007/s00268-010-0860-2
  6. Macintyre IM, Akoh JA. Improving survival in gastric cancer: review of operative mortality in English language publications from 1970. Br J Surg 1991;78:771-776. https://doi.org/10.1002/bjs.1800780703
  7. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-425. https://doi.org/10.1007/BF01655804
  8. Korenaga D, Tsujitani S, Haraguchi M, Okamura T, Tamada R, Sugimachi K, et al. Long-term survival in Japanese patients with far advanced carcinoma of the stomach. World J Surg 1988;12:236-240. https://doi.org/10.1007/BF01658063
  9. Kockerling F, Reck T, Gall FP. Extended gastrectomy: who benefits? World J Surg 1995;19:541-545. https://doi.org/10.1007/BF00294716
  10. McCall MD, Graham PJ, Bathe OF. Quality of life: a critical outcome for all surgical treatments of gastric cancer. World J Gastroenterol 2016;22:1101-1113. https://doi.org/10.3748/wjg.v22.i3.1101
  11. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376. https://doi.org/10.1093/jnci/85.5.365
  12. Sprangers MA, Cull A, Groenvold M, Bjordal K, Blazeby J, Aaronson NK. The European organization for research and treatment of cancer approach to developing questionnaire modules: an update and overview. EORTC quality of life study group. Qual Life Res 1998;7:291-300. https://doi.org/10.1023/A:1008890401133
  13. Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, et al. The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 1995;31A:2260-2263.
  14. van der Schaaf M, Derogar M, Lagergren P. Reference values of oesophago-gastric symptoms (EORTC QLQ-OG25) in a population-based setting. Eur J Cancer 2012;48:1602-1607. https://doi.org/10.1016/j.ejca.2011.10.026
  15. Fayers P, Bottomley A; EORTC Quality of Life Group; Quality of Life Unit. Quality of life research within the EORTC-the EORTC QLQ-C30. European organisation for research and treatment of cancer. Eur J Cancer 2002;38 Suppl 4:S125-S133.
  16. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645-654. https://doi.org/10.1093/ije/29.4.645
  17. Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, et al. Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 2014;50:1330-1344. https://doi.org/10.1016/j.ejca.2014.01.029
  18. Tomaszewski KA, Puskulluoglu M, Biesiada K, Bochenek J, Nieckula J, Krzemieniecki K. Validation of the polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer. J Psychosoc Oncol 2013;31:191-203. https://doi.org/10.1080/07347332.2012.761323
  19. Kim AR, Cho J, Hsu YJ, Choi MG, Noh JH, Sohn TS, et al. Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg 2012;256:1008-1013. https://doi.org/10.1097/SLA.0b013e31827661c9
  20. Onate-Ocana LF, Velazquez-Monroy N, Vazquez L, Espinosa-Mireles-de-Villafranca P, Nunez-Rosas E, Ovando-Lezama M, et al. Clinical validation of the EORTC QLQ-OG25 questionnaire for the evaluation of health-related quality of life in Mexican patients with esophagogastric cancers. Psychooncology 2012;21:745-753. https://doi.org/10.1002/pon.1974
  21. Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y, et al. Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer 2015;18:147-158. https://doi.org/10.1007/s10120-014-0344-4

Cited by

  1. Targeted literature review of the global burden of gastric cancer vol.12, pp.None, 2016, https://doi.org/10.3332/ecancer.2018.883
  2. Effect of early oral feeding on length of hospital stay following gastrectomy for gastric cancer: a Japanese multicenter, randomized controlled trial vol.48, pp.9, 2016, https://doi.org/10.1007/s00595-018-1665-4
  3. Chronological changes in quality of life and body composition after gastrectomy for locally advanced gastric cancer vol.98, pp.5, 2016, https://doi.org/10.4174/astr.2020.98.5.262
  4. Postprandial Changes in Gastrointestinal Hormones and Hemodynamics after Gastrectomy in Terms of Early Dumping Syndrome vol.20, pp.3, 2016, https://doi.org/10.5230/jgc.2020.20.e24
  5. The pattern of postoperative quality of life following minimally invasive gastrectomy for gastric cancer: a prospective cohort from Korean multicenter robotic gastrectomy trial vol.99, pp.5, 2016, https://doi.org/10.4174/astr.2020.99.5.275
  6. Alterations in Small Intestine and Liver Morphology, Immunolocalization of Leptin, Ghrelin and Nesfatin-1 as Well as Immunoexpression of Tight Junction Proteins in Intestinal Mucosa after Gastrectomy vol.10, pp.2, 2016, https://doi.org/10.3390/jcm10020272
  7. Development and Validation of a Symptom-Focused Quality of Life Questionnaire (KOQUSS-40) for Gastric Cancer Patients after Gastrectomy vol.53, pp.3, 2016, https://doi.org/10.4143/crt.2020.1270
  8. Postoperative morbidity and quality of life between totally laparoscopic total gastrectomy and laparoscopy-assisted total gastrectomy: a propensity-score matched analysis vol.21, pp.1, 2016, https://doi.org/10.1186/s12885-021-08744-1